In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Related Posts
Phase III BREAKWATER Trial Shows Braftovi-Based Regimen Improves Survival in BRAF V600E-Mutant Metastatic Colorectal Cancer
Credit: Sebastian Kaulitzki | stock.adobe.com Key Takeaways First-Line Survival Milestone in BRAF V600E mCRCThe Braftovi (encorafenib) combination regimen is the…
Phase III PERSEUS Trial Data Show Darzalex Faspro Combo Improves Survival in Newly Diagnosed Multiple Myeloma
Image credit: David A Litman | stock.adobe.com The FDA will evaluate Johnson & Johnson’s supplemental Biologics License Application (sBLA) for…
How AI Can Ease Recruitment Burdens in Resource-Strained Trials
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts…